Tumor Treating Fields Suppression of Ciliogenesis Enhances Temozolomide Toxicity

Tumor Treating Fields (TTFields) are low-intensity, alternating intermediate-frequency (200 kHz) electrical fields that extend survival of glioblastoma patients receiving maintenance temozolomide (TMZ) chemotherapy. How TTFields exert efficacy on cancer over normal cells or interact with TMZ is uncl...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Ping, Tian, Jia, Ulm, Brittany S., Mallinger, Julianne C., Khoshbouei, Habibeh, Deleyrolle, Loic P., Sarkisian, Matthew R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962950/
https://www.ncbi.nlm.nih.gov/pubmed/35359402
http://dx.doi.org/10.3389/fonc.2022.837589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962950/
https://www.ncbi.nlm.nih.gov/pubmed/35359402
http://dx.doi.org/10.3389/fonc.2022.837589

Ejemplares similares